▁Prem 9.5
ature 2.462890625
▁men 6.1171875
op 0.0224609375
ause 0.01143646240234375
, 2.65625
▁ob 8.6875
es 0.073974609375
ity 0.0006518363952636719
, 0.83203125
▁and 1.2509765625
▁a 4.37890625
▁pre 5.296875
dis 1.009765625
position 0.030029296875
▁to 0.20263671875
▁breast 2.5390625
▁cancer 0.056121826171875
▁present 8.7421875
▁a 1.1044921875
▁unique 3.34375
▁set 1.892578125
▁of 0.0018463134765625
▁challeng 0.74169921875
es 0.0013933181762695312
▁when 3.302734375
▁dec 3.908203125
iding 0.002033233642578125
▁on 1.509765625
▁a 1.662109375
▁treatment 1.76953125
▁plan 0.88818359375
▁for 1.421875
▁middle 8.6796875
- 0.198974609375
aged 0.037933349609375
▁women 0.282958984375
. 0.30224609375
▁Two 7.37109375
▁potential 6.75
▁options 2.12109375
▁for 1.8232421875
▁sympt 5.55859375
om 0.1517333984375
▁relief 0.6259765625
▁are 0.89111328125
▁Met 10.9375
op 2.94921875
rol 0.032196044921875
ol 0.0005865097045898438
▁and 0.5849609375
▁Nor 6.5546875
vas 1.4892578125
c 0.0015020370483398438
. 0.414794921875
▁However 4.265625
, 0.00817108154296875
▁it 3.130859375
▁is 0.469482421875
▁cru 3.90234375
cial 0.0025577545166015625
▁to 0.2174072265625
▁evaluate 3.8984375
▁the 0.79736328125
▁potential 2.3515625
▁ris 1.673828125
ks 2.110004425048828e-05
▁and 0.482421875
▁benefits 0.0858154296875
▁of 0.2352294921875
▁each 0.349853515625
▁medic 0.74951171875
ation 0.0004546642303466797
▁in 2.607421875
▁this 2.650390625
▁specific 1.884765625
▁context 2.35546875
, 2.853515625
▁as 0.9306640625
▁well 1.4248046875
▁as 0.006481170654296875
▁consider 3.1015625
▁how 5.0078125
▁di 6.53515625
et 0.057891845703125
▁and 0.67626953125
▁sm 8.8984375
oking 0.0005578994750976562
▁factor 6.40234375
▁into 0.1453857421875
▁the 0.5205078125
▁overall 2.458984375
▁treatment 1.3251953125
▁plan 0.280517578125
. 0.034698486328125
<0x0A> 0.293701171875
Met 1.369140625
op 0.005977630615234375
rol 0.00011432170867919922
ol 0.00010073184967041016
▁and 1.0009765625
▁Nor 0.02728271484375
vas 0.0023899078369140625
c 0.00012421607971191406
▁are 0.42529296875
▁both 0.9736328125
▁commonly 2.9140625
▁pres 0.498291015625
cribed 0.0002753734588623047
▁medic 0.646484375
ations 0.0097808837890625
▁that 2.40625
▁differ 7.28515625
▁in 0.212890625
▁their 0.58935546875
▁mechan 2.083984375
isms 0.0012636184692382812
▁of 0.044708251953125
▁action 0.0020599365234375
▁and 0.89599609375
▁potential 0.7958984375
▁side 0.0758056640625
▁effects 0.0037174224853515625
. 0.0855712890625
▁Met 1.0791015625
op 0.0009336471557617188
rol 3.3974647521972656e-05
ol 5.602836608886719e-06
▁is 0.35107421875
▁a 0.1298828125
▁beta 0.113037109375
- 0.1275634765625
block 0.0227203369140625
er 0.0139923095703125
, 1.2294921875
▁primarily 5.29296875
▁used 0.10455322265625
▁to 0.144775390625
▁manage 4.1015625
▁hy 1.70703125
pert 4.291534423828125e-06
ension 0.0004413127899169922
▁and 0.72265625
▁card 3.2734375
i 0.55810546875
ov 0.0002837181091308594
asc 4.3511390686035156e-05
ular 6.4373016357421875e-06
▁conditions 1.52734375
. 1.08203125
▁As 7.5078125
▁a 0.457275390625
▁beta 0.336181640625
- 0.030517578125
block 0.004352569580078125
er 0.005096435546875
, 0.00855255126953125
▁it 0.68212890625
▁reduces 2.873046875
▁heart 1.2861328125
▁rate 0.0112762451171875
▁and 0.2298583984375
▁blood 0.432373046875
▁pressure 0.0245361328125
. 2.185546875
▁On 2.341796875
▁the 0.0004982948303222656
▁other 0.0033664703369140625
▁hand 0.0009112358093261719
, 0.0006356239318847656
▁Nor 0.00908660888671875
vas 0.0002332925796508789
c 1.33514404296875e-05
▁is 0.0673828125
▁a 0.186767578125
▁calci 0.03216552734375
um 8.344650268554688e-06
▁channel 0.041748046875
▁block 0.0020694732666015625
er 0.00028252601623535156
▁that 1.6953125
▁dil 2.759765625
ates 0.00021398067474365234
▁blood 0.2294921875
▁vessels 0.00044465065002441406
, 1.0478515625
▁primarily 6.91015625
▁used 0.1580810546875
▁to 0.177734375
▁treat 0.58203125
▁hy 1.1669921875
pert 5.245208740234375e-06
ension 0.0003814697265625
▁and 0.32763671875
▁ang 0.243408203125
ina 0.00013065338134765625
. 0.11785888671875
<0x0A> 0.67236328125
When 1.9326171875
▁it 0.93408203125
▁comes 0.00031566619873046875
▁to 0.0005807876586914062
▁the 2.373046875
▁ris 3.955078125
ks 3.719329833984375e-05
▁of 2.353515625
▁using 2.75390625
▁Met 0.65673828125
op 0.001750946044921875
rol 0.0034160614013671875
ol 3.4570693969726562e-06
▁instead 10.15625
▁of 0.0042877197265625
▁Nor 0.035552978515625
vas 0.001018524169921875
c 0.00017321109771728516
▁for 1.9111328125
▁tre 3.458984375
ating 2.7418136596679688e-05
▁the 3.197265625
▁sympt 0.396484375
oms 0.001373291015625
▁of 0.03961181640625
▁prem 0.60009765625
ature 0.0003955364227294922
▁men 0.007541656494140625
op 6.246566772460938e-05
ause 0.0007405281066894531
▁in 3.14453125
▁middle 1.1357421875
- 0.00457000732421875
aged 0.0032939910888671875
▁women 0.019683837890625
▁with 1.7763671875
▁ob 0.5390625
es 0.00019538402557373047
ity 3.3736228942871094e-05
▁and 0.11181640625
▁a 0.0540771484375
▁pre 0.131103515625
dis 0.001010894775390625
position 0.0013866424560546875
▁to 0.0413818359375
▁breast 0.0029392242431640625
▁cancer 0.00023674964904785156
, 0.0110321044921875
▁several 3.501953125
▁factors 0.56201171875
▁need 1.853515625
▁to 0.003631591796875
▁be 0.0001800060272216797
▁considered 0.1820068359375
. 0.029998779296875
▁First 1.466796875
ly 0.7548828125
, 0.0006184577941894531
▁Met 0.7646484375
op 0.0013828277587890625
rol 0.00015497207641601562
ol 1.7881393432617188e-06
' 6.12890625
s 0.00010573863983154297
▁beta 2.251953125
- 0.004116058349609375
block 0.0019969940185546875
ing 0.1939697265625
▁effects 1.5244140625
▁may 0.9130859375
▁lead 2.998046875
▁to 0.00015342235565185547
▁decre 3.0546875
ased 0.005626678466796875
▁card 4.28125
iac 0.158203125
▁output 0.0731201171875
, 0.6044921875
▁particularly 3.36328125
▁in 0.154052734375
▁individuals 2.365234375
▁with 0.06658935546875
▁underlying 2.029296875
▁card 0.87841796875
i 0.324951171875
ov 0.00016820430755615234
asc 4.291534423828125e-06
ular 2.5272369384765625e-05
▁conditions 0.6650390625
. 0.290283203125
▁Additionally 1.7265625
, 6.747245788574219e-05
▁beta 1.857421875
- 0.0138397216796875
block 0.0006117820739746094
ers 0.01067352294921875
▁have 1.478515625
▁been 0.03564453125
▁associated 0.415771484375
▁with 7.56978988647461e-05
▁weight 3.142578125
▁gain 0.0045928955078125
, 0.67578125
▁which 0.380859375
▁could 1.43359375
▁be 2.560546875
▁problem 1.330078125
atic 1.1086463928222656e-05
▁for 0.423583984375
▁women 1.412109375
▁already 2.341796875
▁struggling 0.408935546875
▁with 0.01202392578125
▁ob 0.087158203125
es 6.854534149169922e-05
ity 3.4570693969726562e-06
. 0.061981201171875
▁Furthermore 2.94140625
, 0.0001233816146850586
▁studies 4.78515625
▁have 0.0849609375
▁suggested 1.310546875
▁a 2.576171875
▁potential 0.97509765625
▁link 0.72265625
▁between 8.20159912109375e-05
▁beta 0.35595703125
- 0.004528045654296875
block 0.0005621910095214844
ers 0.131591796875
▁and 0.0116729736328125
▁an 0.66162109375
▁increased 0.0116424560546875
▁risk 0.0019588470458984375
▁of 0.00952911376953125
▁breast 0.274169921875
▁cancer 0.0009832382202148438
. 0.77978515625
▁This 4.1640625
▁risk 1.2998046875
▁is 1.2099609375
▁of 4.64453125
▁particular 0.048065185546875
▁concern 0.0203094482421875
▁for 0.6123046875
▁women 0.298095703125
▁with 0.3212890625
▁a 0.049835205078125
▁pre 0.50634765625
dis 0.004489898681640625
position 0.0010538101196289062
▁to 0.03582763671875
▁breast 1.2099609375
▁cancer 8.630752563476562e-05
. 1.2783203125
<0x0A> 0.1832275390625
On 0.80517578125
▁the 8.33272933959961e-05
▁other 0.00287628173828125
▁hand 0.0005650520324707031
, 0.0001518726348876953
▁Nor 0.10125732421875
vas 0.00023365020751953125
c 5.364418029785156e-06
' 0.7646484375
s 4.112720489501953e-05
▁potential 4.21484375
▁benefits 1.2626953125
▁include 2.220703125
▁dil 6.0546875
ating 0.090087890625
▁blood 0.09173583984375
▁vessels 5.3763389587402344e-05
, 0.369384765625
▁which 0.54150390625
▁could 0.95263671875
▁contribute 7.10546875
▁to 0.0028076171875
▁man 6.57421875
aging 6.842613220214844e-05
▁blood 4.984375
▁pressure 0.022491455078125
▁and 0.30126953125
▁card 3.458984375
i 0.167236328125
ov 8.594989776611328e-05
asc 1.0609626770019531e-05
ular 3.731250762939453e-05
▁health 2.384765625
, 3.10546875
▁especially 2.076171875
▁in 0.494384765625
▁ob 3.091796875
ese 0.0025730133056640625
▁individuals 0.95849609375
. 0.1358642578125
▁However 1.7099609375
, 4.565715789794922e-05
▁Nor 1.3427734375
vas 0.00010383129119873047
c 3.540515899658203e-05
▁has 1.9599609375
▁been 0.541015625
▁associated 0.250244140625
▁with 0.00012123584747314453
▁peri 4.71484375
pher 0.0006628036499023438
al 0.00013756752014160156
▁ed 0.200927734375
ema 0.0008759498596191406
, 0.478759765625
▁or 3.2265625
▁sw 0.31689453125
elling 0.00811004638671875
, 1.8525390625
▁as 2.4296875
▁a 0.50537109375
▁common 3.8359375
▁side 0.02630615234375
▁effect 0.0017337799072265625
. 0.357421875
▁This 1.1552734375
▁may 2.740234375
▁not 1.166015625
▁be 0.06103515625
▁ideal 2.58203125
▁for 0.08062744140625
▁women 0.470947265625
▁with 0.84619140625
▁ob 1.2744140625
es 0.00173187255859375
ity 1.0132789611816406e-05
▁as 3.517578125
▁it 0.60205078125
▁can 1.671875
▁ex 1.2998046875
ac 0.0022144317626953125
erb 1.1920928955078125e-05
ate 4.1365623474121094e-05
▁the 1.0732421875
▁dis 3.34765625
com 0.0023975372314453125
fort 0.0002225637435913086
▁already 4.34375
▁experienced 1.83203125
. 2.7890625
▁Nevertheless 6.35546875
, 0.00024259090423583984
▁Nor 2.330078125
vas 6.103515625e-05
c 0.00021708011627197266
▁is 1.9921875
▁not 1.65625
▁linked 2.759765625
▁to 0.13330078125
▁an 1.0390625
▁increased 0.0224609375
▁risk 0.01412200927734375
▁of 0.0034122467041015625
▁breast 0.01401519775390625
▁cancer 0.00019466876983642578
, 0.7900390625
▁which 0.4951171875
▁is 0.7421875
▁positive 6.15234375
▁for 0.4443359375
▁those 3.619140625
▁with 0.495849609375
▁a 0.040618896484375
▁pre 0.08306884765625
dis 0.0005421638488769531
position 0.0012464523315429688
▁to 0.246337890625
▁the 0.1986083984375
▁disease 0.106201171875
. 0.004764556884765625
<0x0A> 0.0271453857421875
Cons 4.83203125
ider 0.10302734375
ing 0.1102294921875
▁di 3.90625
et 0.0002453327178955078
▁and 0.09979248046875
▁sm 0.035797119140625
oking 2.5153160095214844e-05
▁in 2.35546875
▁this 1.80859375
▁treatment 3.505859375
▁plan 0.10009765625
▁is 0.66357421875
▁essential 1.66796875
▁for 2.46484375
▁optim 3.43359375
izing 0.07958984375
▁health 1.58203125
▁out 0.2391357421875
comes 4.172325134277344e-06
. 0.1611328125
▁Ob 2.751953125
es 0.250244140625
ity 5.435943603515625e-05
▁is 1.416015625
▁a 0.51220703125
▁known 2.87109375
▁risk 0.032135009765625
▁factor 0.00028777122497558594
▁for 0.0022258758544921875
▁card 2.212890625
i 0.0011196136474609375
ov 0.001834869384765625
asc 3.814697265625e-06
ular 3.814697265625e-06
▁disease 0.161865234375
, 0.64404296875
▁and 0.61474609375
▁a 2.291015625
▁health 0.71630859375
y 0.00693511962890625
▁di 0.026123046875
et 1.2159347534179688e-05
▁can 1.4599609375
▁play 2.416015625
▁a 0.052581787109375
▁cru 0.7978515625
cial 3.5762786865234375e-07
▁role 0.00044226646423339844
▁in 0.0008172988891601562
▁weight 2.3984375
▁management 0.05291748046875
▁and 0.744140625
▁reducing 2.205078125
▁card 2.509765625
i 0.0188751220703125
ov 0.0027618408203125
asc 4.649162292480469e-06
ular 4.851818084716797e-05
▁ris 2.53125
ks 5.4836273193359375e-06
. 0.009521484375
▁Enc 6.66015625
ou 5.125999450683594e-06
rag 0.0009851455688476562
ing 0.00572967529296875
▁a 1.2705078125
▁bal 1.556640625
anced 3.814697265625e-06
▁di 0.4111328125
et 2.6226043701171875e-06
, 2.646484375
▁rich 2.443359375
▁in 0.00019538402557373047
▁f 0.306884765625
ruits 0.00024068355560302734
, 0.5361328125
▁veget 0.0006661415100097656
ables 5.7816505432128906e-05
, 0.00662994384765625
▁whole 1.4765625
▁gra 0.0007696151733398438
ins 0.0001443624496459961
, 0.0037097930908203125
▁and 0.0975341796875
▁lean 0.10345458984375
▁protein 0.6689453125
, 0.8681640625
▁while 2.18359375
▁limit 0.55322265625
ing 3.814697265625e-06
▁processed 0.732421875
▁food 0.1759033203125
s 0.01546478271484375
, 1.4580078125
▁added 1.7734375
▁sug 0.1265869140625
ars 5.125999450683594e-06
, 0.005519866943359375
▁and 0.004764556884765625
▁un 1.6552734375
he 0.000873565673828125
alth 2.7418136596679688e-06
y 0.00038814544677734375
▁f 0.006656646728515625
ats 1.6689300537109375e-06
, 0.306884765625
▁is 2.48828125
▁necessary 5.02734375
▁for 0.51318359375
▁overall 2.6875
▁health 0.269287109375
▁improvement 5.125
. 0.10430908203125
<0x0A> 1.001953125
In 3.078125
▁the 3.615234375
▁case 1.392578125
▁of 0.001308441162109375
▁Met 3.548828125
op 0.002716064453125
rol 3.409385681152344e-05
ol 1.9311904907226562e-05
, 0.56201171875
▁di 2.79296875
et 0.00662994384765625
ary 0.99609375
▁consider 1.85546875
ations 4.887580871582031e-06
▁are 0.859375
▁cru 2.501953125
cial 8.499622344970703e-05
▁due 4.390625
▁to 0.00015723705291748047
▁the 1.41015625
▁potential 0.603515625
▁for 2.1328125
▁weight 0.0421142578125
▁gain 0.0001538991928100586
. 0.5087890625
▁Coun 8.9453125
sel 0.01141357421875
ing 0.0012788772583007812
▁patients 0.72412109375
▁about 3.791015625
▁maintain 2.376953125
ing 4.029273986816406e-05
▁a 0.01812744140625
▁health 0.09393310546875
y 0.0008134841918945312
▁di 0.82275390625
et 6.4373016357421875e-06
▁and 0.62158203125
▁ens 5.03515625
uring 1.430511474609375e-06
▁they 0.6435546875
▁understand 1.7822265625
▁potential 5.43359375
▁weight 1.01171875
▁fl 4.60546875
uct 1.990795135498047e-05
u 3.826618194580078e-05
ations 0.018463134765625
▁associated 2.474609375
▁with 0.0002872943878173828
▁the 0.484375
▁medic 0.10626220703125
ation 0.0005927085876464844
▁can 1.3955078125
▁help 0.428466796875
▁manage 2.169921875
▁any 3.234375
▁ad 3.115234375
verse 0.0003933906555175781
▁effects 0.226318359375
. 0.332275390625
▁Furthermore 3.498046875
, 3.135204315185547e-05
▁coun 4.3515625
sel 0.0021419525146484375
ing 0.0011205673217773438
▁on 1.333984375
▁sm 0.8369140625
oking 0.00011157989501953125
▁c 0.020172119140625
ess 1.7523765563964844e-05
ation 5.125999450683594e-06
▁is 0.50439453125
▁param 4.3828125
ount 5.960464477539062e-07
, 1.1181640625
▁as 0.1241455078125
▁sm 0.40234375
oking 0.0067291259765625
▁is 0.859375
▁associated 3.275390625
▁with 0.0005240440368652344
▁an 0.78955078125
▁increased 0.01494598388671875
▁risk 0.00478363037109375
▁of 0.020416259765625
▁card 0.300048828125
i 0.0017557144165039062
ov 1.0371208190917969e-05
asc 7.033348083496094e-06
ular 2.6106834411621094e-05
▁disease 0.06341552734375
▁and 0.439453125
▁breast 1.796875
▁cancer 8.475780487060547e-05
. 0.214599609375
▁Com 7.21875
bin 0.98779296875
ing 0.01165771484375
▁the 3.24609375
▁use 1.2373046875
▁of 0.00036787986755371094
▁Met 0.234375
op 0.0013456344604492188
rol 0.0005450248718261719
ol 5.245208740234375e-06
▁with 0.1903076171875
▁sm 0.75634765625
oking 0.00020837783813476562
▁c 0.032501220703125
ess 9.071826934814453e-05
ation 2.944469451904297e-05
▁inter 2.681640625
vent 0.0196380615234375
ions 9.5367431640625e-07
▁can 0.32666015625
▁provide 3.396484375
▁a 1.7666015625
▁compreh 0.9638671875
ensive 3.218650817871094e-05
▁approach 0.39111328125
▁to 0.0562744140625
▁patient 6.68359375
▁care 0.23486328125
. 0.31201171875
<0x0A> 0.0204620361328125
For 4.14453125
▁those 2.3203125
▁treated 8.390625
▁with 0.0106048583984375
▁Nor 0.03314208984375
vas 0.00027942657470703125
c 6.723403930664062e-05
, 0.0289306640625
▁di 0.7109375
et 0.0007343292236328125
ary 0.25634765625
▁recommend 3.041015625
ations 2.5033950805664062e-06
▁should 2.673828125
▁pre 9.5859375
domin 0.039825439453125
antly 0.0182342529296875
▁focus 0.2568359375
▁on 0.0005893707275390625
▁the 4.1171875
▁management 1.564453125
▁of 0.005947113037109375
▁ob 3.345703125
es 0.0005116462707519531
ity 2.9802322387695312e-06
▁and 0.88671875
▁card 2.0859375
i 0.002193450927734375
ov 0.00200653076171875
asc 2.6226043701171875e-06
ular 1.2278556823730469e-05
▁health 0.85693359375
. 0.12890625
▁Sm 4.76171875
oking 0.00876617431640625
▁c 0.08953857421875
ess 3.230571746826172e-05
ation 1.2636184692382812e-05
▁advice 4.73046875
▁should 1.333984375
▁still 2.416015625
▁be 0.018280029296875
▁provided 0.96484375
, 0.57421875
▁but 1.4765625
▁with 3.814453125
▁the 3.05078125
▁absence 6.62109375
▁of 0.0006465911865234375
▁Met 7.17578125
op 0.0008363723754882812
rol 0.0018186569213867188
ol 0.0013208389282226562
, 1.6904296875
▁the 0.86376953125
▁potential 2.1953125
▁interactions 7.625
▁between 1.1806640625
▁medic 3.1875
ation 0.55712890625
▁and 0.0227508544921875
▁sm 0.98974609375
oking 0.0006084442138671875
▁are 0.68994140625
▁mit 5.75
ig 1.0848045349121094e-05
ated 0.00038909912109375
. 0.1260986328125
<0x0A> 0.7080078125
In 0.74462890625
▁conclusion 0.35791015625
, 0.0001735687255859375
▁the 1.923828125
▁choice 1.9072265625
▁between 0.37109375
▁Met 0.0269317626953125
op 0.00042891502380371094
rol 0.00010204315185546875
ol 4.172325134277344e-06
▁and 0.06597900390625
▁Nor 0.0006666183471679688
vas 3.9458274841308594e-05
c 1.2755393981933594e-05
▁for 0.410400390625
▁tre 0.87109375
ating 3.4570693969726562e-06
▁the 0.2427978515625
▁sympt 0.005565643310546875
oms 0.0004968643188476562
▁of 0.0016489028930664062
▁prem 0.0220947265625
ature 4.374980926513672e-05
▁men 0.0004820823669433594
op 5.841255187988281e-06
ause 4.4226646423339844e-05
▁in 0.0496826171875
▁middle 0.030303955078125
- 0.0004963874816894531
aged 0.00018143653869628906
▁women 0.0018568038940429688
▁with 0.01061248779296875
▁ob 0.0032863616943359375
es 2.193450927734375e-05
ity 9.894371032714844e-06
▁and 0.006511688232421875
▁a 0.006610870361328125
▁pre 0.0034637451171875
dis 3.790855407714844e-05
position 0.0001533031463623047
▁to 0.0016469955444335938
▁breast 0.00018131732940673828
▁cancer 2.9325485229492188e-05
▁requires 1.4697265625
▁careful 0.399169921875
▁consideration 0.056671142578125
▁of 0.21630859375
▁potential 1.2197265625
▁ris 0.278076171875
ks 1.1920928955078125e-07
▁and 0.06219482421875
▁benefits 0.004764556884765625
. 0.265869140625
▁It 3.26953125
▁is 0.05450439453125
▁essential 1.072265625
▁to 0.0374755859375
▁assess 2.912109375
▁the 1.2568359375
▁impact 5.15625
▁of 0.044464111328125
▁each 1.564453125
▁medic 0.061187744140625
ation 0.00014007091522216797
▁on 0.0955810546875
▁card 0.300537109375
i 0.00475311279296875
ov 0.00041484832763671875
asc 2.9802322387695312e-06
ular 1.4901161193847656e-05
▁health 0.08746337890625
, 0.2548828125
▁weight 1.15234375
▁management 0.426513671875
, 0.0033817291259765625
▁and 0.03729248046875
▁breast 0.86669921875
▁cancer 0.004337310791015625
▁risk 0.039794921875
. 0.74462890625
▁Moreover 4.0390625
, 8.893013000488281e-05
▁a 2.970703125
▁compreh 1.3076171875
ensive 3.24249267578125e-05
▁treatment 2.16796875
▁plan 0.06365966796875
▁should 2.3203125
▁include 1.23046875
▁di 0.61279296875
et 4.851818084716797e-05
ary 0.1292724609375
▁recommend 1.2490234375
ations 1.430511474609375e-06
▁and 0.66162109375
▁sm 0.1251220703125
oking 5.4836273193359375e-06
▁c 0.00226593017578125
ess 1.3947486877441406e-05
ation 1.3232231140136719e-05
▁support 3.8203125
▁to 0.650390625
▁optimize 0.34619140625
▁overall 1.634765625
▁health 0.09539794921875
▁out 0.10748291015625
comes 1.430511474609375e-06
. 0.09967041015625
▁Coll 8.71875
abor 0.0026531219482421875
ative 1.9677734375
▁decision 2.345703125
- 0.00843048095703125
making 7.486343383789062e-05
▁involving 4.7421875
▁patients 1.810546875
, 0.4501953125
▁health 0.86572265625
care 0.016937255859375
▁prov 0.09967041015625
iders 2.7418136596679688e-06
, 0.0034923553466796875
▁and 0.005504608154296875
▁special 2.560546875
ists 0.09033203125
▁is 0.84619140625
▁cru 0.7900390625
cial 4.410743713378906e-06
▁in 1.18359375
▁tail 3.326171875
oring 0.00209808349609375
▁the 2.201171875
▁treatment 1.005859375
▁plan 0.2183837890625
▁to 0.1165771484375
▁the 0.8984375
▁individual 0.77783203125
▁needs 2.099609375
▁of 0.2308349609375
▁each 0.11553955078125
▁patient 0.0220947265625
, 3.767578125
▁maxim 2.7890625
izing 0.001087188720703125
▁benefits 4.46484375
▁while 1.40625
▁minim 0.0753173828125
izing 9.1552734375e-05
▁ris 0.8017578125
ks 2.5033950805664062e-06
. 0.03485107421875
